Cystic fibrosis (CF) is an autosomal recessive genetic disease that significantly affects the patient's health and quality of life. It primarily affects the respiratory and digestive systems, causing chronic and progressive symptoms that can significantly shorten life expectancy. In recent decades, the development of therapeutic approaches and early diagnosis have improved survival and quality of life, but understanding the pathogenesis of the disease and exploring new treatment options remain essential. This article will discuss in detail the pathogenesis, prevalence, symptoms, diagnosis, treatment options, and strategies to improve quality of life of cystic fibrosis.

Pathogenesis and spread of the disease

Cystic fibrosis is one of the most common fatal genetic diseases in the European population, caused by abnormalities in the CFTR (cystic fibrosis transmembrane conductance regulator) gene. The CFTR gene encodes a chloride channel located on the surface of epithelial cells, and its dysfunction leads to the formation of thick and viscous secretions that clog the channels of various organs.

The genetic basis of cystic fibrosis

The genetic causes of cystic fibrosis are linked to more than 2,000 different mutations in the CFTR gene, located on chromosome 7. The most common mutation is ΔF508, which is responsible for approximately 70% of cases in the European population. As a result of this mutation, the chloride channel does not reach the cell membrane or is non-functional, causing a disturbance in the exchange of chloride and sodium ions, which contributes to the production of thicker mucus.

Disease prevalence and demography

Cystic fibrosis is most common in the population of European descent, with approximately 1 in 2,500 births. It is less common in other ethnic groups. In Latvia, the exact prevalence data may differ, but it is estimated that the disease has a similar frequency as in other European countries. Thanks to the latest diagnostic and treatment methods, the life expectancy of patients has increased significantly in recent years.

Symptoms and diagnostics

Cystic fibrosis is manifested by various symptoms associated with damage to the respiratory, digestive and other systems. Early diagnosis is essential to ensure effective treatment and improve patient survival and quality of life.

Main symptoms

Symptoms often appear in early childhood and may include:

• Chronic cough: often associated with bronchial obstruction and infections
• Frequent lung infections: pseudomonas aeruginosa is a common pathogen
• Respiratory disorders: associated with airflow obstruction and obstructive pulmonary disease
• Pancreatic dysfunction: causes malabsorption and nutrient deficiency
• Saltier sweat: use of sweat test in diagnosis

As the disease progresses, you may develop:

• Lung damage: Structural changes occur in the lungs
• Diabetes mellitus: CF associated with pancreatic lesions
• Liver diseases: cirrhosis and other complications
• Infertility: Pelvic duct obstruction is common in men

Diagnostic methods

Diagnosis of cystic fibrosis is usually carried out as part of newborn screening and includes several methods:

• Sweat test: the gold standard that measures chloride ion levels in sweat. Elevated levels indicate CF
• Genetic testing: for detection of CFTR mutations to help confirm the diagnosis
• Additional tests: lung function tests and imaging such as chest X-rays and CT scans to evaluate for complications

Diagnostic accuracy is essential to ensure proper treatment and care.

Treatment options

Physiotherapy and the importance of nutrition

Physiotherapy is essential in the care of cystic fibrosis patients:

• Chest physiotherapy: helps clear the airways using percussion and vibration techniques
• Breathing exercises: improves lung health and promotes gas exchange

Nutritional therapy focuses on ensuring adequate intake of calories and nutrients:

• High calorie meals: to compensate for malabsorption, often involving fat and protein
• Enzyme and vitamin supplements: supports digestion and prevents deficiencies, especially of fat-soluble vitamins

Specifics of nutritional therapy

• Diet: an energy- and nutrient-dense diet, such as a high-protein, high-fat diet
• Supplementation of fat-soluble vitamins (A, D, E, K).: prevents deficiency due to fat malabsorption, especially important for children

Improving quality of life

Quality of life is an important aspect of cystic fibrosis patient care and requires a comprehensive approach that includes not only physical but also psychological support.

Psychological support

Psychological support helps patients and their families cope with the challenges of the disease:

• Psychotherapy: individual or group sessions to promote emotional well-being
• Support groups: sharing experiences with other patients and family members
• Consultations: to deal with stress, depression and anxiety, to help adapt to the challenges associated with the disease

Education about the disease and patient involvement in the treatment plan are essential.

Innovative therapies and future perspectives

Innovative therapies such as gene therapy and CFTR correction agents offer hope for more effective cystic fibrosis treatments in the future:

• Gene therapy: aims to repair or replace the damaged CFTR gene using viral vectors or other delivery systems
• CRISPR technology: offers a more precise approach to mutation repair, potentially correcting genetic defects directly in cells

Research continues to improve the effectiveness of the therapy and expand its availability to all patients.

Social and legal support systems

Various social and legal support mechanisms are available to cystic fibrosis patients and their families:

• Right to medical care: access to needed health care and resources
• Financial support: social guarantees and financial support such as disability pensions
• Education about the disease: educating patients and the public about cystic fibrosis and its consequences

Patient organizations and associations often offer resources and support that can help navigate the complex health care system.

Safety considerations and management of side effects

Cystic fibrosis treatment is often long-term and can be associated with side effects:

• CFTR modulators: May cause liver dysfunction and other effects such as headache and rash

Conclusions

Cystic fibrosis is a complex genetic disease with diverse symptoms and challenges in diagnosis and treatment. Thanks to the development of medicine, the life expectancy and quality of patients has improved significantly. Further research and innovations in therapy promise to bring even greater progress in the management of the disease. It is important to continue efforts to educate the public and support patients and their families to ensure the best possible outcomes.

Concluding remarks

Further research and community involvement can significantly improve the lives of cystic fibrosis patients. Increasing awareness of the disease and its complications can aid in early recognition and more effective treatment. In addition, it is important for national policy makers to provide support mechanisms that facilitate access to needed medical care and resources.